DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,054 filers reported holding DANAHER CORPORATION in Q4 2021. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,439 | +3.4% | 5,802 | 0.0% | 0.66% | -3.9% |
| Q2 2023 | $1,392 | -80.9% | 5,802 | -79.9% | 0.69% | -79.4% |
| Q1 2023 | $7,291 | +49.7% | 28,928 | +57.6% | 3.34% | +20.6% |
| Q4 2022 | $4,871 | -99.9% | 18,353 | 0.0% | 2.77% | -9.4% |
| Q3 2022 | $4,740,000 | +3.5% | 18,353 | +1.6% | 3.05% | +32.4% |
| Q2 2022 | $4,578,000 | -13.6% | 18,058 | 0.0% | 2.30% | -17.8% |
| Q1 2022 | $5,297,000 | -12.3% | 18,058 | -1.6% | 2.80% | +6.5% |
| Q4 2021 | $6,038,000 | +74.7% | 18,353 | +61.7% | 2.63% | +67.2% |
| Q3 2021 | $3,456,000 | +13.4% | 11,353 | 0.0% | 1.58% | +4.9% |
| Q2 2021 | $3,047,000 | +19.3% | 11,353 | 0.0% | 1.50% | +6.5% |
| Q1 2021 | $2,555,000 | +41.2% | 11,353 | +39.4% | 1.41% | -9.1% |
| Q4 2020 | $1,809,000 | +3.2% | 8,142 | 0.0% | 1.55% | -28.7% |
| Q3 2020 | $1,753,000 | -65.2% | 8,142 | -71.5% | 2.18% | -62.8% |
| Q2 2020 | $5,044,000 | +241.3% | 28,522 | +167.1% | 5.85% | +215.2% |
| Q1 2020 | $1,478,000 | -9.8% | 10,678 | 0.0% | 1.86% | -15.1% |
| Q4 2019 | $1,639,000 | +6.3% | 10,678 | 0.0% | 2.19% | +28.3% |
| Q3 2019 | $1,542,000 | -71.2% | 10,678 | -71.5% | 1.71% | -38.5% |
| Q2 2019 | $5,362,000 | -10.5% | 37,518 | -17.3% | 2.77% | -8.2% |
| Q1 2019 | $5,993,000 | – | 45,392 | – | 3.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |